Christina Coughlin
Director/Board Member presso AVACTA GROUP PLC
Provenienza dei contatti di primo grado di Christina Coughlin
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 14 | |
Private Company | Biotechnology | 13 | |
Public Company | Biotechnology | 9 | |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021.
2
| Private Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christina Coughlin tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chairman | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
RADIUS HEALTH, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Commerzbank Finance Ltd.
Commerzbank Finance Ltd. Investment Banks/BrokersFinance Part of Commerzbank AG, Commerzbank Finance Ltd. is a British company that provides securities brokerage services. The private company is based in London, UK. Commerzbank Finance was founded in 1955. | Investment Banks/Brokers | Director/Board Member Corporate Officer/Principal | |
Draupnir Bio ApS
Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Iroko Pharmaceuticals LLC
Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Private Equity Investor General Counsel | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Masters Business Admin Doctorate Degree | |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Ashfield Health LLC
Ashfield Health LLC Miscellaneous Commercial ServicesCommercial Services Ashfield Healthcare Communications LLC provides healthcare information and communication solutions. Its services include support for data-driven clinical publications, strategic consulting, thought leader programs, advisory boards, disease-state education, live educational events and international congresses, web portals and promotional communications. The company was founded in 1972 and is headquartered in Lyndhurst, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
The University of Reading | College/University | Undergraduate Degree | |
IDRx, Inc.
IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
National Mentor Holdings, Inc.
National Mentor Holdings, Inc. Medical/Nursing ServicesHealth Services National Mentor Holdings, Inc. engages in the provision of health and personal care services. The company was founded in 1980 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
Dyno Therapeutics, Inc.
Dyno Therapeutics, Inc. BiotechnologyHealth Technology Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
EQRX, INC. | Pharmaceuticals: Major | Director/Board Member | |
CIVITAS SOLUTIONS INC | Hospital/Nursing Management | Director/Board Member | |
Imperial College London | College/University | Graduate Degree | |
Clinigen CTS Ltd.
Clinigen CTS Ltd. Medical DistributorsDistribution Services Part of Triley Bidco Ltd., Clinigen CTS Ltd. is a British company that provides investigator-initiated studies services to investigators, with managed regulatory pathways required for support of IIS & EAP programs. The private company is based in Burton-On-Trent, UK and has more than 30 years ’ experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company helps Pharmaceutical and Biotech companies grant access to unlicensed medicines around the globe. Clinigen's controlled drug handling services include five DEA registrations: manufacturer, importer, exporter, distributor, and retail pharmacy services. The company also offers a Patient Advocate Fellowship. | Medical Distributors | Director/Board Member | |
Clinigen Holdings Ltd.
Clinigen Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Clinigen Holdings Ltd. develops pharmaceutical products. The private company is based in Burton-on-Trent, UK. Clinigen Holdings was founded in 2017. | Pharmaceuticals: Major | Director/Board Member | |
Clinigen SP Ltd.
Clinigen SP Ltd. Pharmaceuticals: MajorHealth Technology Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million. | Pharmaceuticals: Major | Director/Board Member | |
Idis Group Holdings Ltd.
Idis Group Holdings Ltd. MiscellaneousMiscellaneous Part of Triley Bidco Ltd., Idis Group Holdings Ltd. is a holding British company. The private company is based in Burton-on-Trent, UK. Founded in 2005, Idis Group Holdings operates as a holding company. | Miscellaneous | Director/Board Member | |
Idis Ltd.
Idis Ltd. Drugstore ChainsRetail Trade Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom | Drugstore Chains | Director/Board Member | |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Sancilio & Co., Inc.
Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Miscellaneous Commercial Services | Director/Board Member | |
University of Brighton | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 22 |
Stati Uniti | 19 |
Danimarca | 2 |
Italia | 2 |
Settori
Health Technology | 21 |
Commercial Services | 8 |
Consumer Services | 8 |
Health Services | 3 |
Finance | 2 |
Posizioni
Director/Board Member | 182 |
Corporate Officer/Principal | 101 |
Independent Dir/Board Member | 43 |
Chief Executive Officer | 38 |
Chairman | 31 |
Contatti più connessi
Insiders | |
---|---|
James Noble | 39 |
Eliot Forster | 35 |
Shah Hussain | 25 |
Trevor Nicholls | 19 |
Laura Wade-Gery | 19 |
Shaun Chilton | 19 |
Jorge Conde | 18 |
Kristine Peterson | 18 |
Eva-Lotta Allan | 17 |
Mark Goldberg | 17 |
Tony Gardiner | 17 |
Mojirade James | 14 |
Garry Nicholson | 14 |
Mark F. Boshar | 13 |
Andrew Oh | 12 |
- Borsa valori
- Insiders
- Christina Coughlin
- Connessioni Società